Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Tuberculosis and HIV]

O Rogeaux1, F Bricaire, M Gentilini

  • 1Département des maladies infectieuses, parasitaires, tropicales et de santé publique CHU Pitié-Salpêtrière, Paris, France.

La Revue De Medecine Interne
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

French Society of ENT (SFORL) guidelines. Management of acute Bell's palsy.

European annals of otorhinolaryngology, head and neck diseases·2020
Same author

Reanimation : journal de la Societe de reanimation de langue francaise·2020
Same author

Chronic Lyme disease: A scam that should be condemned!

Medecine et maladies infectieuses·2019
Same author

Cost Effectiveness of Quadrivalent Influenza Vaccine Over Trivalent Vaccine in France.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Proceedings of the 2nd seminar on emerging infectious diseases, December 7, 2012 – Current trends and proposals.

Revue d'epidemiologie et de sante publique·2014
Same author

Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis.

European journal of neurology·2013
Same journal

[Atypical low back pain].

La Revue de medecine interne·2026
Same journal

[Polycythemia associated chronic haemolysis].

La Revue de medecine interne·2026
Same journal

[Persistent headaches in a 55 year-old man].

La Revue de medecine interne·2026
Same journal

[Abdominal pain, fever and arthralgia in a 49-year-old woman].

La Revue de medecine interne·2026
Same journal

[Cardiorespiratory functional disorders: A transnosologic approach].

La Revue de medecine interne·2026
Same journal

[Diagnostic evaluation for suspected polycythemia].

La Revue de medecine interne·2026
See all related articles

Tuberculosis is increasingly common in HIV patients due to weakened immunity and high prevalence. Early diagnosis and effective quadritherapy improve outcomes, but drug resistance necessitates prevention strategies.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Public Health

Context:

  • Rising rates of HIV infection globally, particularly in Africa.
  • Co-infection with tuberculosis (TB) is a significant concern, exacerbated by impaired immunity and poor living conditions.
  • TB can manifest early as an indicator of HIV-related immunodeficiency or later due to recent contagion.

Purpose:

  • To highlight the increased frequency of tuberculosis in HIV-infected individuals.
  • To discuss the diagnostic challenges and treatment strategies for TB in this population.
  • To emphasize the importance of early diagnosis and prevention of drug-resistant strains.

Summary:

  • Diagnosis relies on identifying acid-fast bacilli, positive blood cultures, or histological findings, with the tuberculin skin test often being unreliable.

Related Experiment Videos

  • Pulmonary and extrapulmonary TB manifestations are common, affecting sites like lymph nodes, liver, spleen, blood, and meninges.
  • Standard four-drug (quadritherapy) treatment is effective when initiated early, typically lasting 9-12 months, with a growing need for lifelong maintenance therapy and prophylaxis.

    • Impact:

    • Early and effective treatment of TB in HIV patients improves prognosis and reduces mortality.
    • The emergence of drug-resistant TB strains underscores the critical need for transmission prevention, especially in healthcare settings.
    • Further research into optimal treatment durations, drug tolerance, and prophylactic measures is warranted.